Until the advent of immune checkpoint inhibitors (ICIs), definitive radiotherapy (RT)
concurrently with chemotherapy was recommended for unresectable, locally advanced non …

Background A substantial proportion of patients with unresectable stage III non-small-cell
lung cancer (NSCLC) cannot either tolerate or access concurrent chemoradiotherapy, so …

Lung and colon cancers are two of the most common causes of death and morbidity in
humans. One of the most important aspects of appropriate treatment is the histopathological …

Advanced-stage lung cancer (LC) causes significant morbidity and impacts patients' quality
of life (QoL). Exercise has been proven to be safe, feasible, and beneficial for symptom …

Background: More than 50% of patients with lung cancer are admitted to the hospital while
receiving treatment, which is a burden to patients and the healthcare system. This study …

Background: In recent years, the healthcare field has experienced significant advancements.
New diagnostic techniques, treatments, and insights into the causes of various diseases …

Background As the main cause of cancer death, lung cancer imposes seriously health and
economic burdens on individuals, families, and the health system. In China, there is no …

Background Increased body mass index (BMI) and metabolic abnormalities are
controversial prognostic factors of lung cancer. However, the relationship between metabolic …

Background Concurrent programmed death 1 (PD-1) or programmed death ligand 1 (PD-L1)
inhibitors with sequential chemoradiotherapy (SCRT) have been reported in only a limited …

Background Hemophilia care in mainland China has been greatly improved since the
establishment of the Hemophilia Treatment Center Collaborative Network of China …